What is aggressive fibromatosis?

Aggressive fibromatosis, also known as a desmoid tumor, is a rare type of non -signed tumor that comes from the connective tissue of the body. These tumors do not have the ability to spread throughout the body, although they can cause a significant amount of localized damage. Symptoms depend on the location of tumors and may include pain or internal bleeding, although most patients will have no negative symptoms associated with this condition. Treatment usually consists of surgical removal of tumors, if they cause problems, although those who do not lead to unpleasant harmful side effects can be regularly examined for changes. Any questions or concerns about aggressive fibromatosis or the most appropriate treatment options for an individual situation should be discussed with a physician or other doctor.

Although aggressive fibromatosis is considered benign, tumors can cause a lot of damage, even until organs fail. Desmoid tumors are generally not considered cancer, although in manyHA respects in almost the same way as cancer. Tumors lack the ability to spread throughout the body, but are able to destroy tissues and organs near the place where they evolve. The exact cause of aggressive fibromatosis is not clearly understood, although it seems that there is a genetic component. It is quite common to find out that a patient diagnosis of this condition also has family members with desmoid tumors.

In most cases, there are no specific symptoms that indicate the presence of aggressive fibromatosis. If the tumor is near the skin surface, a painless lump may be obvious. Many times this condition is diagnosed with routine diagnostic tests or after symptoms begin to develop.

Treatment for aggressive fibromatosis usually involves surgical removal of the tumor, although there is a high recurrence rate only with surgery. Depending on the location of the tumor may not be a surgeryThe procedure of a viable treatment option. Radiation therapy, chemotherapy and the use of prescription drugs are often used to treat aggressive fibromatosis, either with or without surgery. In the early stages, the tumor may be monitored and treatment can be delayed until symptoms develop or damage to the surrounding organs and tissues. Before deciding on the most suitable treatment plan, it is important that the patient discusses the benefits and risks of any treatment option.